Human Papillomavirus Vaccination: Health Provider Student’s Knowledge, Opinion, and Barriers to Recommendation of Treatment
MetadataShow full item record
Human papillomavirus (HPV) is a sexually transmitted disease that effects 79 million individuals. HPV commonly leads to cervical cancer as well as other anogenital and oropharyngeal cancers. HPV vaccination implemented in 2006 has been proven effective against these cancers, but only if administered prior to exposure. Healthy People 2020 calls for 80% vaccination rates of adolescents age 11-26, which is significantly higher than current rates. Many barriers exist to increase vaccine uptake, but this study specifically focused on medical, nurse practitioner, and physician assistant student’s knowledge and readiness to recommend HPV vaccination. A sample of 122 future healthcare students completed a survey regarding the HPV vaccination, and results show that although students do have some general knowledge about the two available HPV vaccinations there is need for greater education. Providers must have basic knowledge of both the Cervarix and Gardasil vaccinations including target population, side effects, contraindications, and treatment focus to provide adequate, evidence-based practice care to each patient.